Global Inhaled Nitric Oxide Competitive Landscape Professional Research Report 2025

Global Inhaled Nitric Oxide Competitive Landscape Professional Research Report 2025

Research Summary

Inhaled nitric oxide (iNO) is a medical treatment that involves delivering small, controlled amounts of nitric oxide gas directly into a patient＇s lungs to help improve oxygenation and pulmonary blood flow. Nitric oxide is a potent vasodilator, meaning it relaxes and widens blood vessels, particularly in the lungs, which can enhance blood flow to areas with low oxygen levels. This therapeutic approach is commonly used in the treatment of conditions like pulmonary hypertension, acute respiratory distress syndrome (ARDS), and neonatal respiratory failure, particularly in premature infants. By selectively dilating blood vessels in the lungs without affecting other parts of the body, inhaled nitric oxide can improve oxygen exchange and reduce the workload on the heart. It is typically administered through a ventilator or other specialized delivery system and requires careful monitoring to ensure the correct dose is maintained and to avoid potential side effects, such as methemoglobinemia or nitrogen dioxide toxicity.

According to DIResearch's in-depth investigation and research, the global Inhaled Nitric Oxide market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Inhaled Nitric Oxide include Mallinckrodt, Praxair (Linde plc), Air Liquide, BOC Healthcare (Linde Group) etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Inhaled Nitric Oxide. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Inhaled Nitric Oxide market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Inhaled Nitric Oxide market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Inhaled Nitric Oxide industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Inhaled Nitric Oxide Include:

Mallinckrodt

Praxair (Linde plc)

Air Liquide

BOC Healthcare (Linde Group)

Inhaled Nitric Oxide Product Segment Include:

800 ppm

100 ppm

Others

Inhaled Nitric Oxide Product Application Include:

Near-term and Pre-term Infants PPHN

Children and Adult ARDS

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Inhaled Nitric Oxide Industry PESTEL Analysis

Chapter 3: Global Inhaled Nitric Oxide Industry Porter’s Five Forces Analysis

Chapter 4: Global Inhaled Nitric Oxide Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Inhaled Nitric Oxide Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Inhaled Nitric Oxide Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Inhaled Nitric Oxide Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Inhaled Nitric Oxide Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Inhaled Nitric Oxide Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Inhaled Nitric Oxide Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Inhaled Nitric Oxide Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Inhaled Nitric Oxide Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources